A parallel study of BFKB8488A in type 2 diabetes patients recapitulated improvements in HDL-cholesterol, triglycerides, and adiponectin, but did not demonstrate improvements in HbA1c, fasting glucose, or fasting insulin (302). This evidence concerns the gene INS and type 2 diabetes mellitus.